Clinical Trials Logo

Burr-hole Surgery clinical trials

View clinical trials related to Burr-hole Surgery.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04372147 Recruiting - Clinical trials for Chronic Subdural Hematoma

Embolization of the Middle Meningeal Artery for the Prevention of Chronic Subdural Hematoma Recurrence in High Risk Patients (EMPROTECT)

EMPROTECT
Start date: June 22, 2020
Phase: N/A
Study type: Interventional

Standard of care for the management of symptomatic chronic subdural hematomas (SDHs) is neurosurgical burr-hole evacuation followed by drainage. Post-operative recurrence rates may be as high as 10 to 20 %. In particular, recurrence rate increases with antiplatelet and anticoagulant therapy. Middle meningeal artery (MMA) embolization has been proposed as a novel treatment of chronic SDH. The aim of this study is to assess the efficacy of MMA embolization in reducing the risk of chronic SDH recurrence at 6 months after burr-hole surgery as compared with standard medical post-operative treatment in patients at high risk of post-operative recurrence.